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Background: Previous studies have demonstrated positive effects of short-term, intensive weight-loss programs in
obese children.
Objectives: We evaluated the long-term effects of a non-intensive weight management program on the BMI,
glycemic measures and lipid profiles of obese youth.
Methods: Retrospective chart review of 61 obese children followed at our Weight Management Center. During
visits, dietary changes and regular physical activity were recommended. Anthropometric and laboratory parameters
were evaluated.
Results: At the initial visit, the mean age was 11.1 ± 2.6 years. The follow-up period was 47.3 ± 11.1 months; the
number of outpatient visits per year (OV/yr) was 2.9 ± 0.9. At the end of the follow-up, the whole group exhibited
decreased BMI z-score and LDL-cholesterol when compared to the initial visit. In the subset of subjects in whom
OGTT was performed, 2-hour glucose and peak insulin were decreased. Compared to children with≤ 2 OV/year,
those with> 2 OV/year (3.19 ± 0.7) exhibited a significant decrease in their BMI z-score, LDL-cholesterol, 2-hour
glucose, and peak insulin.
Conclusions: Our study suggests that a periodical (~ 3 OV/yr) evaluation in a non-intensive, long-term weight
management program may significantly improve the degree of obesity and cardiovascular risk factors in childhood.
Keywords: Obesity, Weight loss, Dyslipidemia, Impaired glucose tolerance, Insulin resistanceBackground
It is well known that the prevalence of obesity in chil-
dren has reached epidemic proportions: during the
past decade, the prevalence of children with a Body
Mass Index (BMI)> 95th percentile has tripled in all
pediatric age-range groups [1]. Pediatric obesity is
associated with significant medical complications dur-
ing childhood [2], and it is a significant risk factor for
morbidity and mortality in adulthood [2,3]. Most of
the comorbidities of childhood obesity share insulin
resistance as a common underlying mechanism. Such* Correspondence: ritaann.kubicky@tenethealth.com
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reproduction in any medium, provided the orcomorbidities (dyslipidemia, nonalcoholic fatty liver
disease, type 2 diabetes mellitus (DM), hypertension,
obstructive sleep apnea, polycystic ovary syndrome)
tend to cluster in what is known as the metabolic
syndrome [1,4].
Pediatric metabolic syndrome is a predictor of the
metabolic syndrome and type 2 DM in adulthood [5]; in
addition, obesity-associated atherosclerosis begins in
childhood [6] and its rate of progression is greatly
increased by lipid abnormalities. As a result, detecting
and correcting obesity and its associated metabolic ab-
normalities in childhood may help prevent cardiovascu-
lar morbidity and mortality in adulthood.
A number of studies have demonstrated the positive
effects of intensive weight-loss programs in children
[7-11]. Yet, intensive programs are based on frequent
interactions between children, their families, and al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cessarily expensive and short-term. In addition, most of
the beneficial effects of an intensive short-term interven-
tion often do not persist once the program is completed
[12-14].
Since little is known of the long-term impact of a non-
intensive, conventional weight management program in
obese children [15,16], we evaluated the effects of our
Weight Management Program over a 4-year period at
the Section of Endocrinology and Diabetes at St. Chris-
topher’s Hospital for Children in a subset of obese
patients who maintained ongoing periodic follow-up vis-
its. The goals of our study were: 1) to analyze the
changes of BMI z-score, glycemic measures and lipid
profiles at the end of the 4-year follow-up period, and 2)
to correlate these changes with the frequency of the
follow-up visits.
Methods
We conducted a retrospective analysis of the medical
records of obese (BMI> 95th percentile for age and sex)
children and adolescents evaluated between 2001 and
2008 at the Weight Management Center in the Section
of Endocrinology and Diabetes at St. Christopher’s Hos-
pital for Children. All children were identified by track-
ing patients for whom the ICD-9 Code 783.1 was used
(“abnormal weight gain”). Most of these patients were
referred to us by their pediatricians for an evaluation of
overweight/obesity and/or high serum insulin/abnormal
lipid levels.
Inclusion criteria were the following: [1] children with
a BMI> 95th percentile, [2] 1–18 years of age
[3] ≥ 2 years of follow-up, and [4] fasting lipid panel, glu-
cose and insulin obtained at the beginning and at the
end of the follow-up period. Exclusion criteria included:
1) diagnosis of DM (type 1 or type 2) and 2) use of med-
ications known to affect insulin sensitivity or glucose/
lipid metabolism (metformin, insulin, growth hormone).
The Institutional Regulatory Board of Drexel Univer-
sity College of Medicine approved the retrospective ana-
lysis of the medical records.
At the initial visit, a physician screened the obese sub-
jects for metabolic comorbidities, while a registered
dietitian assessed their dietary habits and amount of
physical activity. Generalized handouts geared towards
healthy eating were provided to each subject; the
dietitian reviewed each topic of the handout with the
subjects and their parent/guardian. The topics included:
making healthy food choices (increasing whole grains,
lean meats and lower fat foods into the diet), eating
three balanced meals per day using the plate method,
portion control (measuring portions and learning about
food labels), eliminating beverages containing more than
5 calories except for low fat milk, and making sensiblesnack choices. Thirty minutes of daily physical activity
was recommended to all subjects with a focus on an activ-
ity that the child would enjoy.
At the subsequent visits (scheduled every 2 to
4 months), obese children and adolescents met with a
pediatric nurse practitioner and the dietitian for ap-
proximately 20 minutes with each of the two provi-
ders; in order to measure implementation of the
previous recommendations, during each of the follow-
up visits, the child’s dietary intake and physical activ-
ities were reassessed by patient history and diet and
exercise recall. Patients who reported adhering to the
dietary or physical activity changes were praised and
encouraged to continue. If there was poor adherence
to previous recommendations, or if there was need
for further improvement, efforts were made by the
dietitian and nurse practioner to detect barriers to
change and to help determine alternative ways of en-
gaging patients to adhere.
At each visit, body weight was measured with a bal-
ance scale, and height was measured with a wall-
mounted stadiometer by a trained medical assistant.
BMI was calculated as weight in kilograms divided by
the height in meters squared, and expressed as a z-score
by using the Centers for Disease Control and Prevention
2000 program [17]. Body weight, height and BMI were
compared to the measurements/calculations of the pre-
vious visit by the nurse practitioner and dietitian in
order to monitor each patient’s weight loss/gain and
change in the BMI as standard of care, and as an object-
ive way to measure the likelihood that the patient was
adhering to the dietary and physical activity-related
recommendations.
A fasting lipid panel (total cholesterol, low-density
lipoprotein [LDL] cholesterol, high-density lipoprotein
[HDL] cholesterol, and triglyceride [TG] levels) was
requested yearly. A 2-hour Oral Glucose Tolerance test
(OGTT) was recommended to all children: impaired
glucose tolerance (IGT) and DM were defined as a
2-hour glucose level of 140–199 mg/dL and ≥ 200 mg/
dL, respectively [18]. Insulin resistance was estimated
by using the Homeostasis Model Assessment of Insulin
Resistance (HOMA-IR), calculated as fasting plasma
glucose (mg/dL) x fasting insulin (μU/mL)  405 [19].
Dyslipidemia was defined as high TG (≥ 90th percentile
for age and sex) and/or low HDL-cholesterol (≤ 10th
percentile for age and sex) concentrations [4].
Data were analyzed with SPSS software version
17.0 for Windows (SPSS, Chicago, IL). All data were
expressed as the mean plus or minus SD or range. A
p-value< 0.05 was considered to be statistically signifi-
cant. Differences in the mean values between groups
were evaluated using a Student’s t-test or analysis of
variance.
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A total of 61 children and adolescents met our inclusion
criteria. 39 children were females and 24 were prepuber-
tal; the mean age was 11.1 ± 2.6 years (mean ± SD). With
respect to their ethnicity, 25 were African American, 26
were Hispanic, 7 were Caucasian, 2 Asian and 1 identi-
fied himself as other. The duration of the follow-up
period was 47.3 ± 11.1 months while the number of out-
patient visits per year (OV/yr) was 2.9 ± 0.9.
At the end of the follow-up, children exhibited a sig-
nificant decrease in their BMI z-score (p = 0.03) and
LDL-cholesterol (p = 0.022) (Table 1). In the subset of
children in whom OGTT was performed both at the be-
ginning and at the end of the follow-up period (n = 42),
there was a significant decrease in both the 2-hour glu-
cose (p = 0.004) and peak insulin (p = 0.043) (Table 1).
All children with an initially normal OGTT (n = 37)
maintained a normal OGTT by the end of the follow-up
period, with the exception of 1 child who developed IGT
(2-hr glucose, 141 mg/dL); his HOMA-IR increased and
BMI z-score decreased. 5 children were found with IGT
on their initial OGTT; their BMI z-score and HOMA-IR
were similar to those of children with normal OGTT. In
4 children with IGT, the OGTT normalized by the end
of the follow-up, while the 5th child developed DM. Of
the 4 children with normalized OGTT, 1 child experi-
enced increased BMI z-score and HOMA-IR, 1 child
decreased BMI z-score and increased HOMA-IR, and 2
children increased BMI z-score and decreased HOMA-
IR. The child who became diabetic had decreased BMI
z-score and HOMA-IR by the end of the follow-up
period.
When children were grouped according to changes in
BMI z-score [increased vs. same/decreased BMI z-score
(0.2 ± 0.15 vs. -0.32 ± 0.3, p< 0.001)], those with the
same or decreased BMI z-score exhibited decreasedTable 1 Anthropometric and metabolic characteristics of
the population sample
Initial Visit Last Visit p-value
BMI z-score 2.49 ± 0.4 2.33 ± 0.4 0.03
Fasting glucose (mmol/L)a 4.8 ± 0.5 4.6 ± 0.5 0.08
Fasting insulin (pmol/L)b 145.1 ± 90.3 135.4 ± 100.7 0.56
HOMA-IR 4.5 ± 3 4.1 ± 2.9 0.38
HDL-cholesterol (mmol/L)c 1.2 ± 0.3 1.2 ± 0.3 0.61
LDL-cholesterol (mmol/L)c 2.9 ± 0.9 2.5 ± 0.6 0.022
Triglycerides (mmol/L)d 2.8 ± 1.8 2.3 ± 0.9 0.057
2-hour glucose (mmol/L)a 2.9 ± 0.6 2.5 ± 0.7 0.004
Peak insulin (pmol/L)b 1445.9 ± 869.5 1070.9 ± 748.7 0.043
Results are expressed as mean ± SD. p-values < 0.05 are in bold.
aTo convert to mg/dL divide by 0.0555.
bTo convert to μIU/mL divide by 6.945.
cTo convert to mg/dL divide by 0.0259.
dTo convert to mg/dL divide by 0.0113.fasting insulin (136.7 ± 98.6 vs. 153.5 ± 91 pmol/L, last
vs. initial visit, p< 0.001) and LDL-cholesterol (2.4 ± 0.5
vs. 2.7 ± 0.9 mmol/L, last vs. initial visit, p = 0.02).
Among the 60 subjects for whom a fasting lipid panel
was obtained at the initial visit, 25 children had dyslipi-
demia: 5 with low HDL and high TG, 11 with isolated
low HDL and 9 with isolated high TG; when compared
to those with normal lipid levels, children with abnormal
levels had similar BMI z-scores (Table 2). At the end of
the follow-up period, lipid levels normalized in 15 chil-
dren and remained abnormal in 10 children: the 15
children with normalized lipid levels exhibited a signifi-
cantly decreased BMI z-score (Table 3), unlike those
with persistently abnormal lipid profile.
5 children with normal HDL and TG at baseline devel-
oped dyslipidemia at the end of the follow-up period: 1
child developed both elevated TG and low HDL, 3 chil-
dren had low HDL and 1 developed high TG. These 5
children did not experience any significant change of the
mean BMI-z-score or HOMA-IR at the end of the
follow-up period (Table 3).
When children were divided in two groups according
to their mean number of OV per year (≤ 2 vs. >2;
1.53 ± 0.5 vs. 3.19 ± 0.7, p< 0.001), there were no differ-
ences at the initial visit for any of the metabolic variables
analyzed or for BMI z-score (Table 4). At the end of the
follow-up, children with> 2 OV/yr exhibited a signifi-
cant decrease in their LDL-cholesterol (Table 4) and
BMI z-score (Table 4), while children with ≤ 2 OV/yr did
not. In the group of children who underwent OGTT,
those with> 2 OV/yr experienced a significant decrease
of both the 2-hour glucose (n = 33), (Table 4, p = 0.0001)
and peak insulin (n = 32), (Table 4, p = 0.0036), while chil-
dren with ≤ 2 OV/yr did not (n = 8 and 6, respectively).Discussion
In our multi-ethnic population sample, a non-intensive
(~ 3 visits per year) weight management program that
reinforced healthy dietary modifications and regular daily
activity over a 4-year period resulted in a statisticallyTable 2 Comparison of BMI z-score and metabolic







BMI z-score 2.42 ± 0.4 2.51 ± 0.4 0.42
HDL-cholesterol (mmol/L)a 1.0 ± 0.2 1.3 ± 0.2 < 0.001
Triglycerides (mmol/L)b 1.6 ± 1.0 0.9 ± 0.3 < 0.001
HOMA-IR 4 ± 1.8 4.6 ± 3.1 0.45
Results are expressed as mean ± SD. p-values < 0.05 are in bold.
aTo convert to mg/dL divide by 0.0259.
bTo convert to mg/dL divide by 0.0113.
Table 3 Changes of BMI z-score and metabolic parameters at the last visit according to changes of lipid levels
Abnormal HDL & TG
#
Abnormal HDL & TG
(n=10)
Abnormal HDL & TG
#
Normal HDL & TG
(n=15)
Normal HDL & TG
#
Abnormal HDL & TG
(n=5)
Normal HDL & TG
#
Normal HDL & TG
(n=30)
Initial Visit Last Visit Initial Visit Last Visit Initial Visit Last Visit Initial Visit Last Visit
BMI z-score 2.36 ± 0.4 2.32 ± 0.5 2.49 ± 0.4 2.19 ± 0.3* 2.47 ± 0.5 2.47 ± 0.5 2.52 ± 0.4 2.37 ± 0.4
HDL-cholesterol (mmol/L)a 0.9 ± 0.1 0.9 ± 0.1 1.1 ± 0.3 1.1 ± 0.2 1.2 ± 0.1 1 ± 0.1* 1.3 ± 0.2 1.3 ± 0.3
Triglycerides(mmol/L)b 1.9 ± 1.4 1.3 ± 32 1.6 ± 0.7 1 ± 0.3* 1 ± 0.3 1.3 ± 0.4 0.9 ± 0.3 0.9 ± 0.3
HOMA-IR 4.2 ± 1.9 5.3 ± 3.3 4.7 ± 3.4 3.7 ± 2 4 ± 2.4 3.3 ± 2.4 4.7 ± 3.2 3.9 ± 3.2
Results are expressed as mean ± SD. *p-value < 0.05, last vs. initial visit.
aTo convert to mg/dL divide by 0.0259.
bTo convert to mg/dL divide by 0.0113.
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and improvement of glucose tolerance.
Extensive evidence previously published supports the
effectiveness of intensive weight-loss programs in
children. In a study conducted by Wilfley et al., 204
overweight children were enrolled to determine the
short-term and long-term efficacy of weight-loss and
weight maintenance programs [7]. After 5 months of in-
tensive weekly meetings focused on weight-loss treat-
ment with a multi-disciplinary team, almost 90% of
children exhibited a decreased BMI z-score. At the end
of the weight-loss intervention, the 2 active maintenance
groups experienced a mean change in BMI z-score of –
0.22 from baseline to 2-year follow-up versus the control
group. Such BMI z-score reduction is similar to the one
shown in our study by the end of the 4-year follow-up
(−0.16); however, Wilfley et al. did not evaluate the im-
pact of weight loss on metabolic parameters. Savoye
et al. studied a population of 209 obese children to
evaluate the effects of a 12-month weight management
program on adiposity and metabolic parameters [8]. The
program included exercise, nutrition, and behavior
modification: intervention occurred biweekly the first
6 months and bimonthly thereafter. At the end of study,
the weight-management group experienced a significant
decrease of BMI and HOMA-IR compared to the con-
trol group; conversely, no difference was found relative
to changes in fasting glucose, HDL-cholesterol, LDL-
cholesterol, or blood pressure. Reinehr et al. studied
changes in weight status and cardiovascular disease
(CVD) risk factors in 203 obese children who attended a
1-year outpatient intervention program; enrolled sub-
jects were then evaluated 1 year after the end of the
intervention [20]. The program included weekly meet-
ings with an exercise physiologist as well as once to
twice monthly with a dietitian and a psychologist. Chil-
dren who experienced a reduction of BMI SDS (72% of
the group) at the end of the 12-month intervention
maintained this reduction 1 year later. In addition, chil-
dren with reduced BMI SDS (but not those without)showed improved HDL-cholesterol, LDL-cholesterol,
blood pressure, and HOMA-IR.
Although the positive effects of all these studies were
sustained for a relatively long period of time, the high
costs associated with the frequent utilization of a team of
dietitians, social workers, and exercise physiologists ren-
der this format not widely applicable. In contrast, our
findings suggest that weight management programs
based on less frequent encounters with a smaller team
(pediatric nurse practitioner and a registered dietitian)
may result in a similarly effective and lasting reduction of
obesity and obesity-associated metabolic abnormalities.
The importance of preventing or reducing the severity
of overweight in childhood is supported by a number of
studies demonstrating the link between pediatric obesity
and morbidity and mortality in adulthood. Three previ-
ous studies have identified an association between over-
weight in children and adolescents with increased rates
of death due to coronary heart disease [21,22] and with
death from all causes [22,23]. In a large cohort of
American-Indian subjects followed since childhood [3],
the rate of premature death (before 55 years of age) from
endogenous causes among children in the highest quar-
tile of BMI was more than double than that in children
in the lowest quartile. Of note, the association between
BMI and premature death was attenuated but remained
significant after adjustment for glucose level, cholesterol
level, and blood pressure: thus, some of the effects of
overweight on the risk of premature death may not de-
pend on abnormal glucose and lipid metabolism, or on
hypertension.
In our cohort of 61 children, 5 were found with IGT at
baseline; in 4 of these children, the OGTT normalized
by the end of the 4-year follow-up period, while one
child became diabetic. In a similar study, Weiss et al.
identified 33 children with IGT in a population sample
of 117 obese children [24]. By the end of a 2-year period,
15 of those with IGT reverted to normal glucose toler-
ance while 8 developed Type 2 DM. When compared to
those who reverted to normal glucose tolerance, subjects
Table 4 Changes of BMI z-score and metabolic parameters according to the frequency of clinic visits
≤ 2 Outpatient visits (n=13) p-value >2 Outpatient visits (n=48) p-value
Initial Visit Last Visit Initial Visit Last Visit
Age (years) 10.9 ± 1.64 11.2 ± 2.9 0.71
Sex (male/female) 5/8 17/31 0.84
BMI z-score 2.44 ± 0.4 2.37 ± 0.4 0.66 2.5 ± 0.4 2.32 ± 0.4 0.03
Fasting glucose (mmol/L)a 4.8 ± 0.32 4.5 ± 0.4 0.09 4.8 ± 0.6 4.7 ± 0.5 0.21
Fasting insulin (pmol/L)b 151.4 ± 59.0 150.01 ± 95.8 0.97 143.8 ± 97.2 131.3 ± 102.1 0.54
HOMA-IR 4.7 ± 1.8 4.4 ± 2.9 0.8 4.5 ± 3.2 4 ± 2.9 0.4
HDL-cholesterol (mmol/L)c 1.2 ± 0.2 1.1 ± 0.3 0.25 1.2 ± 0.3 1.2 ± 0.3 0.98
LDL-cholesterol (mmol/L)c 106.2 ± 84.4 97.9 ± 12.3 0.16 111.3 ± 36.7 96.4 ± 23.5 0.022
Triglycerides (mmol/L)d 1.6 ± 1 1.2 ± 0.4 0.20 1.1 ± 0.7 1 ± 0.4 0.13
2-hour glucose (mmol/L)a (n=8) 5.8 ± 1.2 5.3 ± 1.3 0.44 (n=34) 6.3 ± 1.2 5.2 ± 1.0 0.0001
Peak insulin (pmol/L)a (n=6) 1486.9 ± 1039.0 1474.4 ± 1206.3 0.98 (n=32) 1472.3 ± 817.4 952.9 ± 563.2 0.0036
Results are expressed as mean ± SD. p-values < 0.05 are in bold.
aTo convert to mg/dL divide by 0.0555.
bTo convert to μIU/mL divide by 6.945.
cTo convert to mg/dL divide by 0.0259.
dTo convert to mg/dL divide by 0.0113.
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baseline and increased their BMI during the follow-up
period; in our study, the relationship between OGTT
results and initial BMI z-score and/or change in BMI
z-score overtime is less clear. While the association be-
tween IGT and risk to develop DM has not been well
defined in children, it has been clearly demonstrated
in adults [25,26]; in addition, IGT in adults appears to
be linked to an increased risk for cardiovascular dis-
ease and mortality [27,28].
In the present study, 25 of the 60 subjects had dyslipi-
demia at the initial visit: by the end of the 4-year follow-
up period, in 15 of these 25 subjects the abnormal lipid
levels normalized: unlike those with persistently abnor-
mal lipid panel, the 15 children with normalized lipid
levels exhibited a significantly decreased BMI z-score
during the 4-year follow-up period. Previous cross-
sectional studies have shown a high prevalence of low
HDL-cholesterol and elevated TG in obese children
[29,30]. A longitudinal study conducted in the United
Kingdom in more than 5,000 children showed that 1 SD
greater BMI at age 9–12 years was associated with high
TG and low HDL-cholesterol at age 15–16 years [31]; in
the same study, changing from overweight/obese at age
9–12 to normal weight at age 15–16 was associated with
better cardiovascular risk profiles than remaining over-
weight/obese from childhood through adolescence. Data
from 4 prospective cohorts have demonstrated that car-
diovascular risk factors in childhood (including high TG)
significantly predict subclinical atherosclerosis as early
as 9 years of age [32], thus justifying sustained efforts to
correct obesity and lipid abnormalities in children.
There are some limitations of our study, such as the
lack of a control group and the relatively small samplesize. However, the fact that our results are consistent
with those of studies including a larger number of sub-
jects and a control group supports the validity of our
findings. In addition, there may have been a selection
bias regarding the subjects included in the retrospective
analysis, since only a small number of children initially
evaluated at our Weight Management Center were even-
tually followed for 2 or more years. We can speculate
that the effects of the program were less significant for
those subjects followed for less than 2 years. Those sub-
jects having a longer duration of follow-up may have
experienced weight loss early in the program, greater ad-
herence to the lifestyle changes, or more family involve-
ment. Our results demonstrate that a non-intensive
weight management program offers potential medical
benefits to children and adolescents who are sufficiently
motivated to continue their follow-up visits.
The long duration of our retrospective study, and the
non-intensive approach of our intervention, has ren-
dered unfeasible the concomitant evaluation of a con-
trol, completely untreated, group of obese children. To
circumvent such limitation, we have used two historical
control groups followed longitudinally by Reinehr et al.
[33] and by D’Hondt et al. [34]. In the former study, 100
overweight children [BMI-SDS 1.92 (1.27-2.75)] with a
mean age of 9 years (6–15 years) were periodically eval-
uated during a 2-year period without any intervention.
This control group did not experience any significant
change in their BMI-SDS. In the latter study by D’Hondt
et al., at baseline 50 overweight children (8 of which
were obese) had a mean age of 11.6 ± 0.8 years and a
baseline BMI z-score range of 1.55 ± 0.39 (1.00; 2.64).
2 years later, even these children’s BMI z-scores remained
unchanged. These finding suggests that the significant
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depends on the lifestyle modifications reinforced by our
team, rather than simply reflecting a physiological change
in adiposity.
In conclusion, our study suggests that a non-intensive,
long-term weight management program may significantly
improve the degree of obesity and some cardiovascular
risk factors in childhood. In addition, this non-intensive
treatment (a small team approach) is more likely to be
reimbursed by 3rd party payors making it more financially
sustainable. Prospective studies with a larger population
sample and comparison to a control group are warranted
to confirm these findings.
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